concerns have arisen over its association with a rare but potentially fatal brain infection called progressive multifocal ...

None of these patients were receiving other forms ... Ransohoff, R. M. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease.

10 However, after two cases of progressive multifocal leukoencephalopathy (PML) were confirmed in TYSABRI-treated patients, the drug was voluntarily removed from the market in February 2005 ...

His medical history was significant for AIDS, progressive multifocal leukoencephalopathy ... before being admitted to the hospital. The patient was also taking topiramate for two months before ...

Delay BRIUMVI administration in patients with an active infection until the infection is resolved. Consider the potential for increased immunosuppressive effects when initiating BRIUMVI after ...

Over five years, relapsing-remitting multiple sclerosis patients in France taking Tysabri have adopted more at-home dosing, a ...

Imaging in neurosurgery patients showed how the ... may reduce mortality and improve functional outcomes in progressive ...